Peer Review History
| Original SubmissionOctober 3, 2021 |
|---|
|
PONE-D-21-31806DgDef1, a defensin formed specifically in infected cells of root nodules of the actinorhizal plant Datisca glomerata, induces membrane disruption in Sinorhizobium meliloti 1021PLOS ONE Dear Dr. Pawlowski, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.Specifically, look into the Title, materials and methods, discussion and conclusion section besides detailed comments by the reviewers. Please submit your revised manuscript by 21 Jan 2022. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Dharam Singh Academic Editor PLOS ONE Journal Requirements: 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following in the Acknowledgments Section of your manuscript: The authors would like to thank Peter Lindfors and Anna Pettersson (Stockholm University) for taking care of the D. glomerata and N. benthamiana plants, Robert Benezra (Sloan Kettering Institute) for the gift of plasmid H2-Venus, Max Griesmann (LMU Munich) for providing a new transcriptome assembly for completing the ORFs of DgDef3 and DgDEF4, and Doreen Meier (Philipps-Universität Marburg) for handling the RNA samples for sequencing. Confocal microscopy was performed at the Image Facility of Stockholm University (IFSU). This project was financed by a grant from the Swedish research council Vetenskapsrådet (VR 2012-03061) to KP. The authors acknowledge technical assistance and access to resources supported by BMBF grant FKZ 031A533 within the de.NBI network. We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: KP, VR 2012-03061, Vetenskapsrådet, vr.se AB, access to the resources of BMBF grant FKZ 031A533 (network grant for de.NBI); www.bmbf.de The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 3. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide. 4. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data. Additional Editor Comments: Dear Authors, As suggested by the reviewers, manuscript need a major revision with more clarity in the writing at materials and methods, discussion, and conclusion including abstract and title too. Please see the detailed comments from the reviewers. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The manuscript by Salgado et al reports the evolutionary relationship and funcational characterization of nodule-specific defensin DgDef1 from an actinorhizal plant Datisca glomerata. Overall the results are quite interesting, but the manuscript is over descriptive, particularly the Materials and Methods sections and require major revision. Please find below my specific comments: Title need improvement, it can be shorten to precisely emphasizing the main conclusions or posing a question. Line 50: Promoter GUS studied on transgenic... Line 56-59: This part need improvment, authors should bring the key conclusions here, rather than descrition of results. Line 120:Please be specific about the aim of the study, "In this study, we analysed the previously.." analysed for what and why? Line 163-171: Confusion in this part, authors have studied the gene expression only by RT-qPCR or the abundance of genes was estimated by RNAseq first and then RT-qPCR was performed. Line 245: crushed nodules of of D. glomerata? please clarify. Line 247: remove bacteria from ..with Frankia bacteria. Line 252: Authors cited personal communication on multiple occasions, which is not appropriate. What are these communications, just a preliminary observation not validated or published yet? I believe there might be several reports on similar observations, please cite a peer-reviewed published article. Whole Materials and Methods section need rewrting, it should be brief and clear, complete protocols can be provided as supllementary information. Line 462: accession number is missing. Line 467: Please cite the reference for Demina and collaborators work? There is no clear distinction between Results and Discussions sections, discussions section seems repetition of Results section. Rewirte these sections. Line 612: might suggest?? it appears over speculative expression, and authors should avoid such expressions. The arbitrary use of NCRs, ANDs and nodule-specific defensins is confusing, authors should revisit the manuscript and make changes to maintain consistency and to avoid confusions. non-cooperators seems more appropriate term to cheaters. Line 622: there is no need to define the 'cheaters' again, it was already done in the introduction section. Line 626: Please substantiate your statement with a few references. Fig.1 Low bootstrap values were found on majority of the nodes, scale bar is not clear, which model was applied to draw phylogeny. Fig 3. Why the scale bars were not kept same for all figures? Reviewer #2: The authors have studied the effect of nodule-specific defensin DgDef1 using a soil actinobacterium, Streptomyces coelicolor A3(2) M145, and two Gram-negative strains, E. coli K-12 substrain MG1655 and the legume microsymbiont Sinorhizobium meliloti 1021. The manuscript is well planned and written. The following comments can be considered before accepting the article. Add a concluding line highlighting the importance of work in the end of the Abstract. Even in the last paragraph of the importance and novelty of the present study should be highlighted. Line 367 – What author mean by commercial production? I think it can be changed. I suggest all the units of centrifugation can be given in g rather in rpm Media names when used for the first time should be given in full form. In IC50, 50 should be subscript. While mentioning bacterial scientific names full name can be mentioned (Eg: Pichia pastoris). There after it can be mentioned as P. pastoris ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Praveen Rahi Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Legume NCRs and nodule-specific defensins of actinorhizal plants – do they share a common origin? PONE-D-21-31806R1 Dear Dr. Pawlowski, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Dharam Singh Academic Editor PLOS ONE Additional Editor Comments (optional): All concerns have been satisfactorily addressed. The revised version of the manuscript has been improved dramatically. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I can see that authors have addressed all the queries raised, including modifying the title of the manuscript. Reviewer #2: This article was greatly improved compared with the previous manuscript. I believe it has met the request of the Journal, and could be accepted. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Praveen Rahi Reviewer #2: No |
| Formally Accepted |
|
PONE-D-21-31806R1 Legume NCRs and nodule-specific defensins of actinorhizal plants – do they share a common origin? Dear Dr. Pawlowski: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Dharam Singh Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .